Calls
1
u/Richoffpurp
Reddit r/pennystocks
Win Rate
0.0%
return
-70.8%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 10
$6.30
-70.8%
The author argues GRI Bio is a high-risk micro-cap with a large gap between its ~$0.28 price and analyst targets of $10-$30. The claimed mechanism is positive Phase 2a data (Jan 2026) for lead drug GRI-0621 in IPF, which reportedly stopped lung function decline in twice as many patients versus standard care. An $8 million December offering is said to resolve Nasdaq minimum-equity compliance, and the next Phase 2b could be a catalyst for a big pharma buyout or partnership. The author explicitly flags this as a high-risk micro-cap play.
Other
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Richoffpurp has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: GRI.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
